{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:26:30Z","timestamp":1788963990163,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["KK.01.1.1.01.0010"],"award-info":[{"award-number":["KK.01.1.1.01.0010"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["KK.01.2.2.03.0006"],"award-info":[{"award-number":["KK.01.2.2.03.0006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Engineering"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.eng.2022.08.007","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T12:46:53Z","timestamp":1662468413000},"page":"54-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Differences in Immunoglobulin G Glycosylation Between Influenza and COVID-19 Patients"],"prefix":"10.1016","volume":"26","author":[{"given":"Marina","family":"Kljakovi\u0107-Ga\u0161pi\u0107 Batinjan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tea","family":"Petrovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frano","family":"Vu\u010dkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irzal","family":"Had\u017eibegovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Radovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Jurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovorka","family":"\u0110erek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Huljev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemka","family":"Markoti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivica","family":"Luk\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Trbojevi\u0107-Akma\u010di\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Lauc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Gudelj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rok","family":"\u010civljak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl B","key":"10.1016\/j.eng.2022.08.007_b0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/44.suppl_2.11","article-title":"The socio-economic burden of influenza","volume":"44","author":"Szucs","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eng.2022.08.007_b0010","doi-asserted-by":"crossref","first-page":"111700","DOI":"10.1016\/j.jenvman.2020.111700","article-title":"Epidemiology and diagnosis, environmental resources quality and socio-economic perspectives for COVID-19 pandemic","volume":"280","author":"Suthar","year":"2021","journal-title":"J Environ Manage"},{"issue":"3","key":"10.1016\/j.eng.2022.08.007_b0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-2600(20)30527-0","article-title":"Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study","volume":"9","author":"Piroth","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.eng.2022.08.007_b0020","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","article-title":"Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics","volume":"20","author":"Petersen","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.eng.2022.08.007_b0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"issue":"10223","key":"10.1016\/j.eng.2022.08.007_b0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.eng.2022.08.007_b0035","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41591-020-0819-2","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"26","author":"Thevarajan","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.eng.2022.08.007_b0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1084\/jem.20101352","article-title":"Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection","volume":"208","author":"Wrammert","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.eng.2022.08.007_b0045","first-page":"381","article-title":"B cell responses to influenza infection and vaccination","volume":"386","author":"Chiu","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.eng.2022.08.007_b0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF01958271","article-title":"Serum IgG subclass concentrations in healthy subjects at different age: age normal percentile charts","volume":"149","author":"Plebani","year":"1989","journal-title":"Eur J Pediatr"},{"issue":"9","key":"10.1016\/j.eng.2022.08.007_b0055","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.bbagen.2011.12.004","article-title":"Alternative glycosylation modulates function of IgG and other proteins\u2014implications on evolution and disease","volume":"1820","author":"Gornik","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.eng.2022.08.007_b0060","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.eng.2022.08.007_b0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.bbagen.2007.06.012","article-title":"The N-linked sugar chains of human immunoglobulin G: their unique pattern, and their functional roles","volume":"1780","author":"Kobata","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.eng.2022.08.007_b0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G glycosylation in aging and diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell Immunol"},{"issue":"8","key":"10.1016\/j.eng.2022.08.007_b0075","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","article-title":"Impact of immune complex size and glycosylation on IgG binding to human Fc\u03b3Rs","volume":"190","author":"Lux","year":"2013","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.eng.2022.08.007_b0080","doi-asserted-by":"crossref","first-page":"9256","DOI":"10.1038\/srep09526","article-title":"Developing the IVIG biomimetic, hexa-Fc, for drug and vaccine applications","volume":"5","author":"Czajkowsky","year":"2015","journal-title":"Sci Rep"},{"issue":"30","key":"10.1016\/j.eng.2022.08.007_b0085","doi-asserted-by":"crossref","first-page":"26733","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc\u03b3RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.eng.2022.08.007_b0090","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.4049\/jimmunol.1002600","article-title":"Fc-glycosylation influences Fc\u03b3 receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12","volume":"185","author":"Forthal","year":"2010","journal-title":"J Immunol"},{"issue":"6532","key":"10.1016\/j.eng.2022.08.007_b0095","doi-asserted-by":"crossref","first-page":"eabc8378","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"issue":"596","key":"10.1016\/j.eng.2022.08.007_b0100","doi-asserted-by":"crossref","first-page":"eabf8654","DOI":"10.1126\/scitranslmed.abf8654","article-title":"High titers and low fucosylation of early human anti-SARS-CoV-2 IgG promote inflammation by alveolar macrophages","volume":"13","author":"Hoepel","year":"2021","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.eng.2022.08.007_b0105","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Invest"},{"issue":"6323","key":"10.1016\/j.eng.2022.08.007_b0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.aai8128","article-title":"IgG antibodies to dengue enhanced for Fc\u03b3RIIIA binding determine disease severity","volume":"355","author":"Wang","year":"2017","journal-title":"Science"},{"issue":"6532","key":"10.1016\/j.eng.2022.08.007_b0115","doi-asserted-by":"crossref","first-page":"eabc8378","DOI":"10.1126\/science.abc8378","article-title":"Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity","volume":"371","author":"Larsen","year":"2021","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.eng.2022.08.007_b0120","doi-asserted-by":"crossref","first-page":"010090","DOI":"10.1074\/mcp.M111.010090","article-title":"High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations","volume":"10","author":"Puci\u0107","year":"2011","journal-title":"Mol Cell Proteomics"},{"issue":"9","key":"10.1016\/j.eng.2022.08.007_b0125","first-page":"1062","article-title":"Robustness and repeatability of GlycoWorks RapiFluor-MS IgG N-glycan profiling in a long-term high-throughput glycomic study","volume":"31","author":"Deri\u0161","year":"2021","journal-title":"Glycobiology"},{"key":"10.1016\/j.eng.2022.08.007_b0130","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fchem.2018.00324","article-title":"Comparison of 2-aminobenzamide, procainamide and RapiFluor-MS as derivatizing agents for high-throughput HILIC-UPLC-FLR-MS N-glycan analysis","volume":"6","author":"Keser","year":"2018","journal-title":"Front Chem"},{"issue":"4","key":"10.1016\/j.eng.2022.08.007_b0135","first-page":"372","article-title":"Composition of the immunoglobulin G glycome associates with the severity of COVID-19","volume":"31","author":"Petrovi\u0107","year":"2021","journal-title":"Glycobiology"},{"issue":"6546","key":"10.1016\/j.eng.2022.08.007_b0140","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1126\/science.abc7303","article-title":"Antibody fucosylation predicts disease severity in secondary dengue infection","volume":"372","author":"Bournazos","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.eng.2022.08.007_b0145","doi-asserted-by":"crossref","first-page":"629193","DOI":"10.3389\/fimmu.2021.629193","article-title":"SARS-CoV-2 causes a different cytokine response compared to other cytokine storm-causing respiratory viruses in severely Ill patients","volume":"12","author":"Olbei","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.eng.2022.08.007_b0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.eng.2022.08.007_b0155","doi-asserted-by":"crossref","first-page":"102945","DOI":"10.1016\/j.ebiom.2020.102945","article-title":"Interferon-\u03b1 alters host glycosylation machinery during treated HIV infection","volume":"59","author":"Giron","year":"2020","journal-title":"EBioMedicine"},{"issue":"17","key":"10.1016\/j.eng.2022.08.007_b0160","doi-asserted-by":"crossref","first-page":"11704","DOI":"10.1074\/jbc.M113.502542","article-title":"The absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function","volume":"289","author":"Kurimoto","year":"2014","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.eng.2022.08.007_b0165","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.06.026","article-title":"Anti-HA glycoforms drive B cell affinity selection and determine influenza vaccine efficacy","volume":"162","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.eng.2022.08.007_b0170","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/glycob\/cwaa018","article-title":"Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases","volume":"30","author":"Irvine","year":"2020","journal-title":"Glycobiology"},{"issue":"13","key":"10.1016\/j.eng.2022.08.007_b0175","doi-asserted-by":"crossref","first-page":"15606","DOI":"10.18632\/oncotarget.7244","article-title":"Sialylated immunoglobulin G can neutralize influenza virus infection through receptor mimicry","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget"}],"container-title":["Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095809922006312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095809922006312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T23:33:08Z","timestamp":1761867188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095809922006312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":35,"alternative-id":["S2095809922006312"],"URL":"https:\/\/doi.org\/10.1016\/j.eng.2022.08.007","relation":{},"ISSN":["2095-8099"],"issn-type":[{"value":"2095-8099","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in Immunoglobulin G Glycosylation Between Influenza and COVID-19 Patients","name":"articletitle","label":"Article Title"},{"value":"Engineering","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eng.2022.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Published by Elsevier LTD on behalf of Chinese Academy of Engineering and Higher Education Press Limited Company.","name":"copyright","label":"Copyright"}]}}